About Curie Capital

Curie Capital, founded in 2018 and headquartered in Amsterdam, is a Life Sciences focused venture capital firm specialized in investing in early-stage companies. We have the experience, risk appetite and funds to invest in talented teams with exciting new medical products. We syndicate with experienced co-investors and support portfolio companies with our broad experiences in various areas and access to our extensive network. Curie Capital brings more to the table than capital; we actually help you to build your company.

We invest in Seed and Series A stage Biotechnology, Pharmaceutical and Medical Technology companies, typically focused on therapeutics, diagnostics or class IIb and III medical devices. From our current fund (Curie Capital 3), we are compliant with the RVO seed capital regulations and therefore invest only in companies that have a Dutch headquarters and that have, so far, not raised more than €3,5 million in equity and/or convertible loan agreements.